Establishing secure connection…Loading editor…Preparing document…

Aristada Patient Enrollment Form

This template is fully customizable. Edit the text, fill out the fields, and send it for signature. Give it a try!

EVZIO Direct Patient Enrollment Form

Customer Service: (844) 805-8884 | Fax completed form to: (844) 805-8885

*Indicates required field

PATIENT INFORMATION

Gender:

PRIMARY PRESCRIPTION INSURANCE

(1) Fill in fields with pharmacy insurance information (NOT medical), OR (2) fax Patient Demographic Information or Patient Insurance Card along with enrollment form.

PRESCRIPTION INFORMATION

Drug: EVZIO® (naloxone HCl injection) 2 mg auto-injector

*Delivery Options:

PRESCRIBER INFORMATION

*Prescriber’s Primary Specialty:

PROVIDER ATTESTATION

By signing below, I verify that the information being disclosed in this enrollment form is complete and accurate to the best of my knowledge. I understand that ASPN Pharmacies, LLC (ASPN) reserves the right at any time and for any reason, without notice, to modify this enrollment form or to modify or discontinue any services or assistance provided through this Program. Finally, I authorize ASPN as my designated agent to use and disclose my patient’s protected health information as may be necessary for treatment, payment, and healthcare operations, including to verify the accuracy of any information provided, to verify patient eligibility, to provide for payment and reimbursement, and to forward the above prescription information, by fax or other mode of delivery, to a pharmacy for fulfillment. Finally, I allow ASPN to email me regarding prescription status updates and act as my prior authorization agent in dealing with prescription and medical insurance companies.

Signature is required to process the prescription. Stamped signatures are not permissible. (Dispense As Written)

PRESCRIBER OFFICE CONTACT INFORMATION

CLINICAL INFORMATION

Diagnosis:

EVZIO Direct Patient Enrollment Form

See Indications and Important Safety Information on reverse. ©2016 kaleo, Inc. All rights reserved. PP-EVZ-US-1185. December 2016. Please see full Prescribing Information at www.EVZIO.com.

Important Safety Information

INDICATION

EVZIO is an opioid antagonist indicated for the emergency treatment of known or suspected opioid overdose, as manifested by respiratory and/or central nervous system depression in adults and pediatric patients. EVZIO is intended for immediate administration as emergency therapy in settings where opioids may be present. EVZIO is not a substitute for emergency medical care.

IMPORTANT SAFETY INFORMATION

EVZIO is contraindicated in patients known to be hypersensitive to naloxone hydrochloride or to any of the ingredients in EVZIO. Seek emergency medical assistance immediately after use. Additional supportive and/or resuscitative measures may be helpful while awaiting emergency medical assistance.

The following warnings and precautions should be taken when administering EVZIO:

• Risk of Recurrent Respiratory and CNS Depression: Due to the duration of action of naloxone relative to the opioid, keep the patient under continued surveillance and administer repeated doses of naloxone using a new EVZIO, as necessary, while awaiting emergency medical assistance.

• Risk of Limited Efficacy with Partial Agonists or Mixed Agonists/Antagonists: Reversal of respiratory depression caused by partial agonists or mixed agonists/antagonists, such as buprenorphine and pentazocine, may be incomplete. Larger or repeat doses may be required.

• Precipitation of Severe Opioid Withdrawal: Use in patients who are opioid dependent may precipitate opioid withdrawal. In neonates, opioid withdrawal may be life-threatening if not recognized and properly treated. Monitor for the development of opioid withdrawal.

• Risk of Cardiovascular (CV) Effects: Abrupt postoperative reversal of opioid depression may result in adverse CV effects. These events have primarily occurred in patients who had pre-existing CV disorders or received other drugs that may have similar CV effects. Monitor these patients closely in an appropriate healthcare setting after use of naloxone hydrochloride.

The following adverse reactions were most commonly observed in EVZIO clinical studies: dizziness and injection site erythema.

Abrupt reversal of opioid effects in persons who were physically dependent on opioids has precipitated signs and symptoms of opioid withdrawal including: body aches, fever, sweating, runny nose, sneezing, piloerection, yawning, weakness, shivering or trembling, nervousness, restlessness or irritability, diarrhea, nausea or vomiting, abdominal cramps, increased blood pressure, and tachycardia. In the neonate, opioid withdrawal signs and symptoms also included: convulsions, excessive crying, and hyperactive reflexes.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Enter text✕

What the Aristada Patient Enrollment Form Is

The Aristada Patient Enrollment Form is a standardized enrollment and benefits intake document used by clinics, specialty pharmacies, and payers to capture patient identity, prescribing clinician details, insurance and pharmacy information, consent for treatment, and authorization to process benefits or prior authorization requests. It supports initiation and ongoing administration of Aristada (aripiprazole lauroxil) therapy by ensuring required clinical, demographic, and payer data are collected in a consistent format to support treatment scheduling, specialty distribution, and reimbursement workflows.

Why a Complete Enrollment Form Matters

A fully completed Aristada Patient Enrollment Form reduces delays in therapy, speeds prior authorization and specialty pharmacy processing, and documents patient consent. Accurate intake minimizes manual follow-up, clarifies insurance coverage, and protects clinical teams from avoidable administrative interruptions.

Why a Complete Enrollment Form Matters

Who Typically Completes or Signs This Form

Clinical staff and specialty pharmacy coordinators usually prepare the form; prescribers, patients, and payer representatives provide required approvals and data.

  • Prescribing clinician or authorized clinician delegate provides clinical diagnosis, dosing, and signature authorization.
  • Patient or legal guardian supplies identity, consent, and insurance payment information for benefits verification.
  • Specialty pharmacy or benefits coordinator enters distribution preferences, prior authorization details, and payer case notes.

Depending on practice size, completion may be delegated to medical assistants, pharmacy liaisons, or centralized benefits teams to ensure timely processing.

Core Sections Included in a Professional Enrollment Form

A well-constructed Aristada Patient Enrollment Form organizes clinical, administrative, and payer data into reusable sections for reliability and electronic processing.

Patient Info

Full legal name, preferred name, date of birth, sex, address, phone, and preferred contact method to ensure accurate matching with payer and pharmacy records.

Insurance

Primary and secondary payer names, plan IDs, group numbers, subscriber name and relationship, and any pharmacy benefit manager (PBM) details needed for prior authorization and claims submission.

Clinical Data

Diagnosis, relevant medical history, current medications, allergies, weight if required, and provider clinical justification to support prior authorization and safe dosing.

Prescriber Details

Prescriber name, NPI, office address, phone/fax, DEA status if applicable, and prescribing clinician signature or electronic attestation to authorize therapy.

Distribution & Pharmacy

Preferred specialty pharmacy, shipping instructions, refill cadence, and patient enrollment in manufacturer assistance or copay programs where applicable.

Consent & Authorization

Patient signature or electronic consent, HIPAA release for health information, and authorization for benefits investigation and electronic communication with payers and pharmacies.

Essential Data Elements Required

Patient Name: Full legal name as on ID
Date of Birth: MM/DD/YYYY
Insurance Details: Payer name, ID, group
Prescriber NPI: 10-digit NPI number
Authorization: Patient consent checkbox
Clinical Diagnosis: ICD-10 or diagnosis text

Step-by-Step: Completing the Enrollment Form

Follow these steps in order to reduce back-and-forth and speed approval for therapy initiation.

  • 01
    Collect Patient Data: Gather ID, insurance, and contact details.
  • 02
    Record Clinical Details: Enter diagnosis, prior meds, and justification.
  • 03
    Attach Documents: Add recent labs, prior auth forms, or notes.
  • 04
    Obtain Signature: Get patient or guardian signature and date.

How to Configure an Online Enrollment Workflow

Set up fields and routing rules so submissions trigger verification and pharmacy handoffs automatically.

Field Configuration
Required Fields Mark patient ID, DOB, insurance, signature required
Conditional Fields Show prior auth fields when payer requires
Routing Auto-send to specialty pharmacy on completion
Notifications Email confirmations to patient and clinic

Typical Submission Flow for an Electronic Enrollment

Understand who receives the form and what happens after submission to manage follow-up and patient scheduling.

  • Clinic Intake: Staff complete form and attach clinical notes.
  • Benefits Check: Coordinator submits to payer for eligibility review.
  • Pharmacy Handoff: Specialty pharmacy receives approved order.
  • Scheduling: Patient appointment scheduled for injection.

Technical Requirements for Digital Completion and Sharing

Confirm that your platform supports secure PDF forms, role-based signing, and secure file transfer before switching to eSubmission.

  • File Formats: PDF, DOCX accepted
  • Integrations: EHR and pharmacy portal connectors
  • Security: TLS with AES-256 at rest

Typical Timelines and Processing Expectations

Processing times vary by payer and pharmacy; set internal SLAs to manage patient expectations and coordinate scheduling.

Benefits Verification:

1–3 business days typical

Prior Authorization:

3–14 business days depending on payer

Specialty Pharmacy Fill:

2–5 business days after approval

Patient Scheduling:

Depends on clinic availability and authorization timing

Appeals:

Up to 30–60 days, per payer rules

Common Mistakes That Delay Enrollment

  • Incomplete or mismatched patient identifiers cause payer verification failures and require manual follow-up with the clinic.
  • Missing prescriber NPI or signature prevents prior authorization submission and can return the request as invalid.
  • Incorrect insurance IDs or omitted subscriber relationships trigger reprocessing and may lead to billing denials.
  • Failure to attach supporting clinical documentation often results in expedited denial of prior authorization or requests for additional records.

Risks of Inaccurate or Noncompliant Forms

HIPAA Exposure: Breach risk, regulatory fines
Coverage Denial: Claim or PA denial risk
Treatment Delay: Therapy initiation postponed
Financial Liability: Patient billed incorrectly
Audit Findings: Documentation deficiencies cited
Legal Risk: Consent disputes or liability

Two Typical Enrollment Scenarios

Real-world examples show how completed forms affect therapy start times and payer approvals in clinic workflows.

Clinic Case

A community mental health clinic completed enrollment online to schedule a first dose appointment quickly.

  • The coordinator attached prior notes and insurance cards.
  • The streamlined submission eliminated two phone calls and reduced scheduling delay from ten days to three days by avoiding common payer verification errors.

Specialty Pharmacy Case

A specialty pharmacy used a standardized enrollment form integrated with its intake portal to automate routing.

  • The pharmacy auto-submitted prior auth forms.
  • This avoided manual rekeying, shortened fill time by several days, and provided an auditable trail for appeals and patient counseling contacts.

Frequently Asked Questions About Enrollment and eSigning

Answers to common operational and compliance questions about completing, signing, and storing the Aristada Patient Enrollment Form.


Need help? Contact support

eSignature Pricing and Feature Comparison Relevant to Enrollment Workflows

Compare common vendor criteria for signing and HIPAA-capable workflows when selecting an eSignature platform to handle patient enrollment securely.

signNow DocuSign Adobe Sign PandaDoc HelloSign
Starting Price $8/user/mo $15/user/mo $14/user/mo $19/user/mo $15/user/mo
Free Trial 7-day free trial Varies by vendor Varies by vendor Varies by vendor Varies by vendor
Bulk Send Yes Yes Yes Yes No
Audit Trail Yes Yes Yes Yes Yes
HIPAA Compliant Yes Yes Yes No No
be ready to get more
Join over 28 million airSlate SignNow users